136 related articles for article (PubMed ID: 26791409)
1. Synthesis and Evaluation of Astatinated N-[2-(Maleimido)ethyl]-3-(trimethylstannyl)benzamide Immunoconjugates.
Aneheim E; Gustafsson A; Albertsson P; Bäck T; Jensen H; Palm S; Svedhem S; Lindegren S
Bioconjug Chem; 2016 Mar; 27(3):688-97. PubMed ID: 26791409
[TBL] [Abstract][Full Text] [Related]
2. Direct procedure for the production of 211At-labeled antibodies with an epsilon-lysyl-3-(trimethylstannyl)benzamide immunoconjugate.
Lindegren S; Frost S; Bäck T; Haglund E; Elgqvist J; Jensen H
J Nucl Med; 2008 Sep; 49(9):1537-45. PubMed ID: 18703591
[TBL] [Abstract][Full Text] [Related]
3. Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo Behavior.
Dekempeneer Y; Bäck T; Aneheim E; Jensen H; Puttemans J; Xavier C; Keyaerts M; Palm S; Albertsson P; Lahoutte T; Caveliers V; Lindegren S; D'Huyvetter M
Mol Pharm; 2019 Aug; 16(8):3524-3533. PubMed ID: 31268724
[TBL] [Abstract][Full Text] [Related]
4. Shelf-life of ɛ-lysyl-3-(trimethylstannyl)benzamide immunoconjugates, precursors for 211At labeling of antibodies.
Aneheim E; Halleröd J; Albertsson P; Jensen H; Holgersson S; Lindegren S
Cancer Biother Radiopharm; 2015 Feb; 30(1):41-5. PubMed ID: 25588020
[TBL] [Abstract][Full Text] [Related]
5. Reagents for astatination of biomolecules: comparison of the in vivo distribution and stability of some radioiodinated/astatinated benzamidyl and nido-carboranyl compounds.
Wilbur DS; Chyan MK; Hamlin DK; Kegley BB; Risler R; Pathare PM; Quinn J; Vessella RL; Foulon C; Zalutsky M; Wedge TJ; Hawthorne MF
Bioconjug Chem; 2004; 15(1):203-23. PubMed ID: 14733601
[TBL] [Abstract][Full Text] [Related]
6. N-[2-(maleimido)ethyl]-3-(trimethylstannyl)benzamide, a molecule for radiohalogenation of proteins and peptides.
Aneheim E; Foreman MRS; Jensen H; Lindegren S
Appl Radiat Isot; 2015 Feb; 96():1-5. PubMed ID: 25474765
[TBL] [Abstract][Full Text] [Related]
7. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination.
Wilbur DS; Chyan MK; Hamlin DK; Vessella RL; Wedge TJ; Hawthorne MF
Bioconjug Chem; 2007; 18(4):1226-40. PubMed ID: 17583925
[TBL] [Abstract][Full Text] [Related]
8. Automated astatination of biomolecules--a stepping stone towards multicenter clinical trials.
Aneheim E; Albertsson P; Bäck T; Jensen H; Palm S; Lindegren S
Sci Rep; 2015 Jul; 5():12025. PubMed ID: 26169786
[TBL] [Abstract][Full Text] [Related]
9. Radioiodinated and astatinated NHC rhodium complexes: synthesis.
Rajerison H; Guérard F; Mougin-Degraef M; Bourgeois M; Da Silva I; Chérel M; Barbet J; Faivre-Chauvet A; Gestin JF
Nucl Med Biol; 2014 May; 41 Suppl():e23-9. PubMed ID: 24661351
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunotherapy with an
Takashima H; Koga Y; Manabe S; Ohnuki K; Tsumura R; Anzai T; Iwata N; Wang Y; Yokokita T; Komori Y; Mori D; Usuda S; Haba H; Fujii H; Matsumura Y; Yasunaga M
Cancer Sci; 2021 May; 112(5):1975-1986. PubMed ID: 33606344
[TBL] [Abstract][Full Text] [Related]
11. Reagents for astatination of biomolecules. 6. An intact antibody conjugated with a maleimido-closo-decaborate(2-) reagent via sulfhydryl groups had considerably higher kidney concentrations than the same antibody conjugated with an isothiocyanato-closo-decaborate(2-) reagent via lysine amines.
Wilbur DS; Chyan MK; Nakamae H; Chen Y; Hamlin DK; Santos EB; Kornblit BT; Sandmaier BM
Bioconjug Chem; 2012 Mar; 23(3):409-20. PubMed ID: 22296587
[TBL] [Abstract][Full Text] [Related]
12. Reagents for astatination of biomolecules. 4. Comparison of maleimido-closo-decaborate(2-) and meta-[(211)At]astatobenzoate conjugates for labeling anti-CD45 antibodies with [(211)At]astatine.
Wilbur DS; Thakar MS; Hamlin DK; Santos EB; Chyan MK; Nakamae H; Pagel JM; Press OW; Sandmaier BM
Bioconjug Chem; 2009 Oct; 20(10):1983-91. PubMed ID: 19731929
[TBL] [Abstract][Full Text] [Related]
13. Bifunctional aryliodonium salts for highly efficient radioiodination and astatination of antibodies.
Guérard F; Navarro L; Lee YS; Roumesy A; Alliot C; Chérel M; Brechbiel MW; Gestin JF
Bioorg Med Chem; 2017 Nov; 25(21):5975-5980. PubMed ID: 28964629
[TBL] [Abstract][Full Text] [Related]
14. Astatine-211-labeled antibodies for treatment of disseminated ovarian cancer: an overview of results in an ovarian tumor model.
Andersson H; Elgqvist J; Horvath G; Hultborn R; Jacobsson L; Jensen H; Karlsson B; Lindegren S; Palm S
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3914S-21S. PubMed ID: 14506189
[TBL] [Abstract][Full Text] [Related]
15. Stability and in vivo behavior of Rh[16aneS4-diol]211 at complex: a potential precursor for astatine radiopharmaceuticals.
Pruszyński M; Łyczko M; Bilewicz A; Zalutsky MR
Nucl Med Biol; 2015 May; 42(5):439-445. PubMed ID: 25687450
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biodistribution of 211At-labeled, biotinylated, and charge-modified poly-L-lysine: evaluation for use as an effector molecule in pretargeted intraperitoneal tumor therapy.
Lindegren S; Andersson H; Jacobsson L; Bäck T; Skarnemark G; Karlsson B
Bioconjug Chem; 2002; 13(3):502-9. PubMed ID: 12009939
[TBL] [Abstract][Full Text] [Related]
17. Preparation and preclinical assessment of folate-conjugated, radiolabelled antibodies.
Henriksen G; Bruland OS; Larsen RH
Anticancer Res; 2005; 25(1A):9-15. PubMed ID: 15816513
[TBL] [Abstract][Full Text] [Related]
18. The pre-clinical characterization of an alpha-emitting sigma-2 receptor targeted radiotherapeutic.
Makvandi M; Lieberman BP; LeGeyt B; Hou C; Mankoff DA; Mach RH; Pryma DA
Nucl Med Biol; 2016 Jan; 43(1):35-41. PubMed ID: 26702785
[TBL] [Abstract][Full Text] [Related]
19. Astatine-211 labeling of an antimelanoma antibody and its Fab fragment using N-succinimidyl p-astatobenzoate: comparisons in vivo with the p-[125I]iodobenzoyl conjugate.
Hadley SW; Wilbur DS; Gray MA; Atcher RW
Bioconjug Chem; 1991; 2(3):171-9. PubMed ID: 1932216
[TBL] [Abstract][Full Text] [Related]
20. Tumor Targeting of
Takashima H; Ohnuki K; Manabe S; Koga Y; Tsumura R; Anzai T; Wang Y; Yin X; Sato N; Shigekawa Y; Nambu A; Usuda S; Haba H; Fujii H; Yasunaga M
Mol Pharm; 2023 Feb; 20(2):1156-1167. PubMed ID: 36573995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
